« Back to Record
Citation APA

Sadones, J., De Greve, J., Neyns, B., Michotte, A., In't Veld, P., Chaskis, C., Sciot, R., Menten, J., Joossens, E. J. R., Strauven, T., D'Hondt, L., Sartenaer, D., Califice, S. F. E. H. S., Bierau, K., & Svensson, C. (2009). MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. European journal of cancer, 45(1), 146-153. doi:10.1016/j.ejca.2008.09.002


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/187004

Sadones, J., De Greve, J., Neyns, B., Michotte, A., In't Veld, P., Chaskis, C., Sciot, R., Menten, J., Joossens, E. J. R., Strauven, T., D'Hondt, L., Sartenaer, D., Califice, S. F. E. H. S., Bierau, K., & Svensson, C. (2009). MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. European journal of cancer, 45(1), 146-153. doi:10.1016/j.ejca.2008.09.002